Finance
Get the app
J&J in talks to buy eye disease biotech Ollin for $3.4 bln, FT reports

BlogZone shows headlines and summaries from public news feeds. The full story is published by Investing.com.
Read the full story at Investing.com →Enjoyed this?
Get more stories like this — and write your own — in the BlogZone app.


